Cancer of unknown primary origin classification: Difference between revisions
Farima Kahe (talk | contribs) Created page with "__NOTOC__ {{Cancer of unknown primary origin}} {{CMG}}; {{AE}} ==Overview== There is no established system for the classification of [disease name]. OR [Disease name] may..." |
|||
Line 34: | Line 34: | ||
==Classification== | ==Classification== | ||
*Cancer of unknown primary origin may be classified into 4 groups initially according to [[light microscopy]] of the [[biopsy]]:<ref name="pmid19262901">{{cite journal |vauthors=Varadhachary GR |title=Carcinoma of unknown primary origin |journal=Gastrointest Cancer Res |volume=1 |issue=6 |pages=229–35 |year=2007 |pmid=19262901 |pmc=2631214 |doi= |url=}}</ref> | |||
:*[[Adenocarcinoma|Adenocarcinomas]] | |||
:*[[Squamous cell carcinoma|Squamous cell carcinomas]] | |||
:*Poorly differentiated tumors | |||
:*[[Neuroendocrine tumor|Carcinomas with neuroendocrine differentiation]] | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | [Disease name] may be classified according to [classification method] into [number] subtypes/groups: |
Revision as of 17:42, 5 February 2019
Cancer of unknown primary origin Microchapters |
Differentiating Cancer of Unknown Primary Origin from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Cancer of unknown primary origin classification On the Web |
American Roentgen Ray Society Images of Cancer of unknown primary origin classification |
Risk calculators and risk factors for Cancer of unknown primary origin classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: [group1], [group2], [group3], and [group4].
OR
[Disease name] may be classified into [large number > 6] subtypes based on [classification method 1], [classification method 2], and [classification method 3]. [Disease name] may be classified into several subtypes based on [classification method 1], [classification method 2], and [classification method 3].
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features: According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].
Classification
- Cancer of unknown primary origin may be classified into 4 groups initially according to light microscopy of the biopsy:[1]
- Adenocarcinomas
- Squamous cell carcinomas
- Poorly differentiated tumors
- Carcinomas with neuroendocrine differentiation
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
OR
Based on the duration of symptoms, [disease name] may be classified as either acute or chronic.
OR
If the staging system involves specific and characteristic findings and features:
According to the [staging system + reference], there are [number] stages of [malignancy name] based on the [finding1], [finding2], and [finding3]. Each stage is assigned a [letter/number1] and a [letter/number2] that designate the [feature1] and [feature2].
OR
The staging of [malignancy name] is based on the [staging system].
OR
There is no established system for the staging of [malignancy name].